Patients Take MedicineNCT02197689
A Trial for a Personalized Medication Management Platform to Improve Medication Adherence
A study testing Personalized Medication Management Platform for SMS Reminder in people with Patients Take Medicine, run by Taipei Medical University.
Trial summary
Taiwan has attracted much attention for its National Health Insurance (NHI) and healthcare system around the world with many countries in Europe and the United States using it as a benchmark. Read more about this study
- Who is it for?
- Ages 20 years and older
- Conditions the study is for
- Patients Take Medicine
- What is being tested?
- Personalized Medication Management Platform for SMS Reminder
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 763 participants
- Where
- No sites listed yet
- Study dates
- Jan 2010to Nov 2012
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 20 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Delayed or forgot to take medications over the last 3 days
- Received a min. 7-day medication prescription
- Able to receive SMS using mobile phones / devices
- 20 years or older
- Having intention to receive active treatment
Who cannot join
- Unable to receive SMS via mobile phones
- Illiterate and < 20 years of age
- Received outpatient prescription drugs for ≤ 7 days
- External use, injections and traditional Chinese medicine
- Planned to go abroad
- Cold, cough, or prescribed with analgesics
About this study
Official title: Mobile Intelligent Personal Medication Management Platform
Taiwan has attracted much attention for its National Health Insurance (NHI) and healthcare system around the world with many countries in Europe and the United States using it as a benchmark. However, increasing medication costs over the past two years account for more than 25% of total expenditure, surpassing every OECD member and mounting increasing pressure on the NHI. Nevertheless, patient medication adherence is relatively low. Thus, the investigators assessed the effectiveness of a personalized medication management system for improving the medication adherence for patients, in order to save long term medication costs.
Read the detailed description
Design, Setting and Patients: The investigators developed a mobile personalized medication management platform (PMMP) to reduce delayed and missed medications. The investigators conducted a randomized control trial in medical centers of northern Taiwan from January 2010 to July 2012 using 1198 participants that missed or delayed their medications during past three days. They received a minimum 7-day to 14-day maximum medication prescription.
Interventions: Patients were randomized into a control group which non-received any SMS reminder for medication using and an intervention group which received a SMS reminder everyday in mobile devices.
Primary Outcome(s) and Measure(s): The primary outcomes were compared patient medication adherence among experimental and control groups.
- Conditions
- Patients Take Medicine
- Being tested
- Personalized Medication Management Platform for SMS Reminder
- Keywords
- Personalized Medication Management, Medication Adherence, SMS Medication Reminder
- Medical subject headings
- Medication Adherence
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Personalized Medication Management Platform for SMS ReminderDevice
The Personalized Medication Management Platform was developed by investigators that integrated with Hospital Information System (HIS) to collect the prescription information of patients and automatically send SMS to remind
| Study group | Role | What they receive |
|---|---|---|
| SMS Medication Reminder | Experimental | 763 patients were assigned to experimental group Receives: Device: Personalized Medication Management Platform for SMS Reminder |
| No SMS Reminder | No intervention | 435 patients were assigned to control group as no SMS reminder |
What is being measured
The primary outcome is the main question the study is designed to answer.
The proportion of patients in delaying and forgetting medications
Measured: Patients who participated in this trial will be sent SMS during 7days
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted23 Jul 2014 (estimated)
- Study startJan 2010
- Primary completionJul 2012
- Study completionNov 2012
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Patients Take MedicineStudies of the same condition, open and under way.
- More trials run by Taipei Medical UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 763 participants (actual)
Sponsor and investigators
- Lead sponsor
- Taipei Medical University
- Sponsor type
- University, hospital or other
- Collaborators
- National Science and Technology Council, Taiwan, Taipei Veterans General Hospital, Taiwan, China Medical University, Taiwan, Taipei Medical University WanFang Hospital, National Yang Ming Chiao Tung University, National Chung Cheng University, National Tsing Hua University, HsinChu City, Taiwan, National Taiwan University, Hwa Hsia Institute of Technology, New Taipei City, Taiwan
- Responsible party
- Sponsor
- Investigators
- Yu-Chuan Li, MD., PhD, Principal investigator, Taipei Medical University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02197689
- Sponsor's protocol ID
- NSC 99-2218-E-038-001
- Status last verified
- Jun 2014
- First submitted
- 17 Jul 2014
- Last updated
- 23 Jul 2014
- Results posted
- No
- Data monitoring committee
- No
Publications
Huang CY, Nguyen PA, Clinciu DL, Hsu CK, Lu JR, Yang HC, Wu CC, Tsai WC, Chou YC, Kuo TBJ, Chang PL, Jian WS, Li YJ. A personalized medication management platform (PMMP) to improve medication adherence: A randomized control trial. Comput Methods Programs Biomed. 2017 Mar;140:275-281. doi: 10.1016/j.cmpb.2016.12.012. Epub 2016 Dec 30.
PubMed 28254084
Study at a glance
From the registry record, last updated by the sponsor on 23 Jul 2014. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Mobile Intelligent Personal Medication Management Platform
- ClinicalTrials.gov ID
- NCT02197689
- Acronym / sponsor ID
- NSC 99-2218-E-038-001
- Conditions
- Patients Take Medicine
- Keywords
- Personalized Medication Management, Medication Adherence, SMS Medication Reminder
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 763 participants (actual)
- Lead sponsor
- Taipei Medical UniversityUniversity, hospital or other
- Collaborators
- National Science and Technology Council, Taiwan, Taipei Veterans General Hospital, Taiwan, China Medical University, Taiwan, Taipei Medical University WanFang Hospital, National Yang Ming Chiao Tung University, National Chung Cheng University, National Tsing Hua University, HsinChu City, Taiwan, National Taiwan University, Hwa Hsia Institute of Technology, New Taipei City, Taiwan
- Study start
- Jan 2010
- Primary completion
- Jul 2012 (actual)
- Study completion
- Nov 2012 (actual)
- First posted
- 23 Jul 2014 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Taiwan has attracted much attention for its National Health Insurance (NHI) and healthcare system around the world with many countries in Europe and the United States using it as a benchmark. However, increasing medication costs over the past two years account for more than 25% of total expenditure, surpassing every OECD member and mounting increasing pressure on the NHI. Nevertheless, patient medication adherence is relatively low. Thus, the investigators assessed the effectiveness of a personalized medication management system for improving the medication adherence for patients, in order to save long term medication costs.
Detailed description
Design, Setting and Patients: The investigators developed a mobile personalized medication management platform (PMMP) to reduce delayed and missed medications. The investigators conducted a randomized control trial in medical centers of northern Taiwan from January 2010 to July 2012 using 1198 participants that missed or delayed their medications during past three days. They received a minimum 7-day to 14-day maximum medication prescription.
Interventions: Patients were randomized into a control group which non-received any SMS reminder for medication using and an intervention group which received a SMS reminder everyday in mobile devices.
Primary Outcome(s) and Measure(s): The primary outcomes were compared patient medication adherence among experimental and control groups.
Study design
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| SMS Medication Reminder | Experimental | Device: Personalized Medication Management Platform for SMS Reminder763 patients were assigned to experimental group |
| No SMS Reminder | No intervention | –435 patients were assigned to control group as no SMS reminder |
Who may qualify
- Ages
- 20 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (5 listed)
- Delayed or forgot to take medications over the last 3 days
- Received a min. 7-day medication prescription
- Able to receive SMS using mobile phones / devices
- 20 years or older
- Having intention to receive active treatment
Key exclusion criteria (6 listed)
- Unable to receive SMS via mobile phones
- Illiterate and < 20 years of age
- Received outpatient prescription drugs for ≤ 7 days
- External use, injections and traditional Chinese medicine
- Planned to go abroad
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Personalized Medication Management Platform for SMS ReminderThe Personalized Medication Management Platform was developed by investigators that integrated with Hospital Information System (HIS) to collect the prescription information of patients and automatically send SMS to remind | Device | SMS Medication Reminder |
Primary outcome
The proportion of patients in delaying and forgetting medications
Time frame: Patients who participated in this trial will be sent SMS during 7days
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 23 Jul 2014.
- Derived from this study: PubMed 28254084Huang CY, Nguyen PA, Clinciu DL, Hsu CK, Lu JR, Yang HC, Wu CC, Tsai WC, Chou YC, Kuo TBJ, Chang PL, Jian WS, Li YJ. A personalized medication management platform (PMMP) to improve medication adherence: A randomized control trial. Comput Methods Programs Biomed. 2017 Mar;140:275-281. doi: 10.1016/j.cmpb.2016.12.012. Epub 2016 Dec 30.
Related trials for Patients Take Medicine
Recruiting
Testing the Effectiveness of a Novel Intervention to Improve Medication Adherence in Stroke Survivors
Stroke, Intracerebral Haemorrhage
RecruitingObservational study
Selective CT for Anticoagulated Head Injured Patients
Head Injury, Traumatic Brain Injury
Not yet recruiting
Testing a Smart Medication Dispenser (Mobili®) to Help People With Chronic Conditions Take Their Medicine
Dose Administration Aids, Medication Adherence
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Yu-Chuan Li, MD., PhD principal investigator
Taipei Medical University
Questions about this trial
What is this clinical trial studying?
A study testing Personalized Medication Management Platform for SMS Reminder in people with Patients Take Medicine, run by Taipei Medical University.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 23 Jul 2014. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
The proportion of patients in delaying and forgetting medications (time frame: Patients who participated in this trial will be sent SMS during 7days). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT02197689, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Jul 2014.